JBSSSANFILIPPO JOHN B & SON INC
- US FDA
FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A
The U.S. Food and Drug Administration today approved Fayuvi (rebisufligene etisparvovec-hopf), the first treatment for pediatric patients with mucopolysaccharidosis type IIIA (MPS IIIA), also known as Sanfilippo syndrome type A., MPS IIIA is a rare inherited disease that progressively damages the brain and nervous system, causing children to lose cognitive, language and other developmental abilities over time. Until today, treatment was limited to managing symptoms; there was no FDA-approved therapy designed to change the underlying course of the disease."The Trump Administration is committed to bringing safe and effective treatments to patients with the most urgent and unmet needs. The appr... ...
- BusinessWire
John B. Sanfilippo & Son, Inc. Reports Fiscal 2026 Fourth Quarter and Full Year Results
Fourth Quarter Net Sales Increased 4.2%; Sales Volume Increased 1.4% John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) (the "Company") today announced financial results for its fiscal 2026 fourth quarter and ...
- GlobeNewswire
John B. Sanfilippo & Son, Inc. 4th Quarter Fiscal Year 2026 Operating Results Conference Call
Elgin, IL, Aug. 12, 2026 (GLOBE NEWSWIRE) -- John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS), a major processor and distributor of snack and recipe nut products and snack bar manufacturer, will hold its quarterly ...
- US Department of Defense
Contracts for July 22, 2026
NAVY Northrop Grumman Systems Corp., Aerospace Systems. Melbourne, Florida, is awarded a not-to-exceed $1,196,000,000 cost, no fee undefinitized contract for the production, delivery, and associated support for three E-2D Advanced Hawkeye Block II aircraft for the Navy. Work will be performed in Melbourne, Florida (29.88%); St. Augustine, Florida (17.68%); Liverpool, New York (13.85%); Indianapolis, Indiana (4.95%); Largo, Florida (3.66%); San Leandro, California (2.52%); Woodland Hills, California (2.42%); Aire-sur-l’Adour, France (2.09%); Rolling Meadows, Illinois (1.72%); Wimborne Minster, Dorset, United Kingdom (0.01%); and various locations within the continental U.S. (21.22%), and is e... ...
- BusinessWire
John B. Sanfilippo & Son, Inc. Announces CEO Transition and Leadership Changes
John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) today announced a CEO and leadership succession plan designed to ensure a seamless leadership transition and the continued execution of its strategic plan. Jeffrey T. ...
- BusinessWire
John B. Sanfilippo & Son, Inc. Declares $1.05 Per Share Special Dividend and a Regular Annual Dividend of $0.95 Per Share
John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) (the "Company") today announced that its Board of Directors (the "Board") declared a special cash dividend (the "Special Dividend") of $1.05 per ...
- Analyst Upgrades
Freedom Broker Initiates Coverage On John B Sanfilippo & Son with Hold Rating, Announces Price Target of $95
Freedom Broker analyst Balzhan Tleuzhanova initiates coverage on John B Sanfilippo & Son with a Hold rating and announces Price Target of $95. ...
- BusinessWire
John B. Sanfilippo & Son to Present and Host 1x1 Investor Meetings at the 16th Annual East Coast IDEAS Investor Conference on June 10th & 11th in New York, NY
John B. Sanfilippo & Son (NASDAQ:JBSS) today announced management will present at the East Coast IDEAS Investor Conference on Thursday June 11, 2026 at The Westin Times Square in New York, NY. The Company's ...
- BusinessWire
John B. Sanfilippo & Son, Inc. Voluntarily Recalls Snack Mix Products Due to Possible Health Risk
As a follow up to the voluntary recall of dry milk powder by California Dairies, Inc. due to the potential presence of Salmonella, John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) (the "Company") announced today that it ...
- BusinessWire
John B. Sanfilippo & Son, Inc. Reports Fiscal 2026 Third Quarter Results
Third Quarter Net Sales Increased 8.0% to a Record $281.8 Million John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) (the "Company") today announced financial results for its fiscal 2026 third quarter ended March 26, ...
- GlobeNewswire
John B. Sanfilippo & Son, Inc. 3rd Quarter Fiscal Year 2026 Operating Results Conference Call
Elgin, IL, April 22, 2026 (GLOBE NEWSWIRE) -- John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS), a major processor and distributor of snack and recipe nut products and snack bar manufacturer, will hold its quarterly ...
- BusinessWire
John B. Sanfilippo & Son, Inc. Declares $1.50 Per Share Special Dividend
John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) (the "Company") today announced that its Board of Directors (the "Board") declared a special cash dividend (the "Special Dividend") of $1.50 per share on all issued and ...
- Analyst Upgrades
BWS Financial Maintains Buy on John B Sanfilippo & Son, Maintains $109 Price Target
BWS Financial analyst Hamed Khorsand maintains John B Sanfilippo & Son with a Buy and maintains $109 price target. ...
- BusinessWire
John B. Sanfilippo & Son, Inc. Reports Fiscal 2026 Second Quarter Results
Record Breaking Net Sales Drove a Diluted EPS Increase of 31.9% to $1.53 per Share John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) (the "Company") today announced financial results for its fiscal 2026 second quarter ...
- Analyst Upgrades
BWS Financial Maintains Buy on John B Sanfilippo & Son, Maintains $109 Price Target
BWS Financial analyst Hamed Khorsand maintains John B Sanfilippo & Son with a Buy and maintains $109 price target. ...
- GlobeNewswire
John B. Sanfilippo & Son, Inc. Declares $1.00 Per Share Special Dividend
Elgin, IL, Oct. 29, 2025 (GLOBE NEWSWIRE) -- John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) (the "Company") today announced that its Board of Directors (the "Board") declared a special cash dividend (the "Special ...
- GlobeNewswire
John B. Sanfilippo & Son, Inc. Reports Fiscal 2026 First Quarter Results
Elgin, IL, Oct. 29, 2025 (GLOBE NEWSWIRE) -- John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) (the "Company") today announced financial results for its fiscal 2026 first quarter ended September 25, 2025. First Quarter ...
- BusinessWire
John B. Sanfilippo & Son, Inc. 1st Quarter Fiscal Year 2026 Operating Results Conference Call
John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS), a major processor and distributor of snack and recipe nut products and snack bar manufacturer, will hold its quarterly conference call to discuss its first quarter ...
- Analyst Upgrades
BWS Financial Initiates Coverage On John B Sanfilippo & Son with Buy Rating, Announces Price Target of $109
BWS Financial analyst Hamed Khorsand initiates coverage on John B Sanfilippo & Son with a Buy rating and announces Price Target of $109. ...
- SEC
ARS Form - Annual Report to Security Holders - SANFILIPPO JOHN B & SON INC (0000880117) (Filer)
Annual Report to Security Holders ...
- SEC
DEFA14A Form - Additional definitive proxy soliciting materials and Rule 14(a)(12) material - SANFILIPPO JOHN B & SON INC (0000880117) (Filer)
Additional definitive proxy soliciting materials and Rule 14(a)(12) material ...
- SEC
DEF 14A Form - Other definitive proxy statements - SANFILIPPO JOHN B & SON INC (0000880117) (Filer)
Other definitive proxy statements ...
- SEC
8-K Form - Current report, items 7.01 and 9.01 - SANFILIPPO JOHN B & SON INC (0000880117) (Filer)
Current report, items 7.01 and 9.01 ...
- Earnings Call Transcripts
John B. Sanfilippo & Son, Inc. (JBSS) Q4 2025 Earnings Call Transcript
John B. Sanfilippo & Son, Inc. (JBSS) Q4 2025 Earnings Call Transcript ...
- BusinessWire
John B. Sanfilippo & Son, Inc. Reports Fiscal 2025 Fourth Quarter and Full Year Results
Fourth Quarter Diluted EPS Increased by 33.7% to $1.15 per Share on Relatively Flat Net Sales John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) (the "Company") today announced financial results for its fiscal 2025 ...